A prospective multicenter study for evaluation of the accuracy and clinical usefulness of the high-sensitivity next-generation sequencing panel using cytological specimens from lung cancer
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000047215
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are deemed inappropriate for participation in this study by the principal investigator or the research coordinator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rates of lung cancer compact panel test using cytological specimen
- Secondary Outcome Measures
Name Time Method 1) Comparison of positive concordance rate and positive predictive value of gene mutation of "companion diagnostic test" and "high-sensitivity lung cancer multi-gene NGS panel test" for cytological specimens 2) Detection rate of gene abnormalities of 8 lung cancer-related genes (EGFR, BRAF, ALK, ROS1, MET, RET, KRAS, HER2) by "high-sensitivity lung cancer multi-gene NGS panel test" for cytological specimens 3) Number of days for reporting test results of "High-sensitivity lung cancer multigene NGS panel test" for cytological specimens